 Anti-Bacterial Agents
"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
| Descriptor ID |
D000900
|
| MeSH Number(s) |
D27.505.954.122.085
|
| Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 3 | 5 | | 1997 | 4 | 1 | 5 | | 1998 | 5 | 4 | 9 | | 1999 | 7 | 6 | 13 | | 2000 | 5 | 3 | 8 | | 2001 | 8 | 4 | 12 | | 2002 | 5 | 2 | 7 | | 2003 | 11 | 9 | 20 | | 2004 | 11 | 7 | 18 | | 2005 | 7 | 13 | 20 | | 2006 | 9 | 6 | 15 | | 2007 | 11 | 10 | 21 | | 2008 | 18 | 14 | 32 | | 2009 | 12 | 14 | 26 | | 2010 | 20 | 14 | 34 | | 2011 | 29 | 12 | 41 | | 2012 | 19 | 16 | 35 | | 2013 | 27 | 15 | 42 | | 2014 | 30 | 14 | 44 | | 2015 | 42 | 23 | 65 | | 2016 | 37 | 27 | 64 | | 2017 | 40 | 20 | 60 | | 2018 | 50 | 26 | 76 | | 2019 | 59 | 29 | 88 | | 2020 | 44 | 49 | 93 | | 2021 | 43 | 57 | 100 | | 2022 | 12 | 77 | 89 | | 2023 | 19 | 66 | 85 | | 2024 | 42 | 51 | 93 | | 2025 | 54 | 20 | 74 | | 2026 | 24 | 13 | 37 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Foong KS, Fowle L, Slider A, Campion M, Leaf J, Cumming M, Bolstorff B, Brandeburg C, McHale E, Reilly C, Beaulac K, Vazquez GA, Koethe B, Doron S, Alsoubani M. A Public Health Approach to Antimicrobial Stewardship in Long-term Care Facilities: A Multifaceted Program in Massachusetts. Clin Infect Dis. 2026 Jul 23; 83(1):e10-e17.
-
Plattner AS, O'Leary S, Katz SE, Andersen LM, Facer EE, Jenkins TC, Stein AB, Thomas G, Koenig N, Frost HM. Differences in Antibiotic Prescribing Patterns for Children with Acute Otitis Media Based on Patient, Clinician, and Clinic Characteristics. J Pediatric Infect Dis Soc. 2026 Jul 06; 15(7).
-
Beck A, Driscoll J, Hoetzer K, Abraham AG, Conway R, Bakalar J, Johnston H, Czaja CA. Association between social vulnerability index and rates of carbapenem-resistant enterobacterales infections in the Denver metropolitan region, 2016-2019. Infect Control Hosp Epidemiol. 2026 Aug; 47(8):840-842.
-
Amajor V, Bwint A, Shein SL, Hume J, Rowan CM, Flygt LP, Malone MP, Stenson EK, Weiss SL, Zinter MS, Kannan S, Dahmer MK, Nofziger RA, Pai MP, Zuppa AF, Rhodes NJ, Hall MW, Scheetz MH, Downes KJ. Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsampling. Antimicrob Agents Chemother. 2026 Jul; 70(7):e0173625.
-
Buffington T, Hoover L. Recognizing and managing neonatal sepsis. JAAPA. 2026 Jun 01; 39(6):28-34.
-
Al Musawa M, El Ghali A, Morrisette T, Banks AL, Saeedi M, Mahoney M, Salam M, Sinclair E, Chen B, Molina KC, Thomas M, Zeuli J, Webb AJ, Holger DJ, Tupayachi-Ortiz MG, Bouchard J, Veve MP, Eubank TA, Raja K, Campion M, Stevens RW, Rybak MJ. Beyond traditional tetracyclines: a real-world evaluation of effectiveness and safety of omadacycline therapy for complex bacterial infections. BMC Infect Dis. 2026 May 25; 26(1).
-
Nguyen TB, Porragas-Paseiro HS, McKenney KM. Obstetric sacroiliac joint injury: a case report and discussion. BMC Pregnancy Childbirth. 2026 May 19; 26(1).
-
Kunz Coyne AJ, Judd C, Lucas K, Al Musawa M, Van Helden S, Holger D, Althubyani A, Yost C, VanDorf S, Mynatt R, Kufel WD, Hayes J, Deri CR, Wrenn RH, Slaton CN, Morrisette T, Davis M, Cabanilla MG, Shald E, White BP, Sassine J, Truong J, Rosenberg J, Andrade J, Cerenzio J, Medvedeva N, Ha D, Eubank TA, Garey KW, Biagi M, Todd M, Kang-Birken SL, Rux C, Molina KC, Jankowski CA, Claeys KC, Venugopalan V, Veve MP, Orzol C, Eshaya M, Caniff KE, Bleick C, Rybak MJ. Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers. Antimicrob Agents Chemother. 2026 06 03; 70(6):e0026826.
-
Detweiler CS, Alav I. How resistance-nodulation-division (RND) efflux pumps contribute to virulence. PLoS Pathog. 2026 May; 22(5):e1014228.
-
O'Toole RV, O'Hara NN, Carlini AR, Schrank GM, Chung S, Gary JL, Obremskey W, Matuszewski PE, Teague D, Natoli RM, Gitajn IL, Weaver MJ, Renninger CH, Levack AE, Degani Y, Collins SC, Weston-Farber E, Howe AL, Thompson RE, Castillo RC, Karunakar MA, Blum L, Harmer L, Hsu JR, Kempton LB, Phelps KD, Seymour RB, Sims SH, Acharya MS, Callahan H, Chavez-Araujo LM, Churchill C, Gambuzza MP, Haim KR, Ishman E, Kendall JS, Mullis ND, Young C, Pilson HT, Carroll EA, Goodman JB, Holden MB, Jones AL, Moon C, Lin CA, Marecek GS, Moffitt GB, Conlan T, George AV, Fisher LA, Mullin DS, Recendez CL, Aneja A, Brameier DT, Heng M, Ly TV, Stenquist DS, Suneja N, Wignakumar T, Borgida JS, Policicchio TJ, Hanson GR, Alese OM, Ricci WM, Behrens SB, Dvorzhinskiy A, Bilodeau RE, Klinger CE, Mullis BH, Jang Y, Lopas LA, McKinley TO, O'Neill DC, Szatkowski JP, Virkus WW, Hill LC, Gaski G, Hymes RA, Ahn J, Goch AM, Holzman M, Malekzadeh AS, Schulman JE, Rivera JC, Krause PC, Bridgman C, Cohen J, Eikani C, Chavez M, Kudulis M, Warner SJ, Achor TS, Choo A, Eastman JG, Kellam PJ, Boutte SJ, Guevara KD, Reid KR, Vallier HA, Tucci AV, Davis JM, Bell AC, Bonyun ME, Healey K, Li V, McKibben NS, Nascone J, Okhuereigbe D, Sciadini MF, Slobogean G, Zingas N, Kovvur M, Lawrence JE, Phipps H, Rudnicki J, Turner KE, Hayda R, Evans AR, Quinnan S, Benitez A, Rehman S, Soderquist MC, Townsend CB, Caroom C, Collins AC, Okwumabua E, Shaikh HS, Spitler CA, Agarwal A, Johnson MD, Haller JM, Marchand LS, Alfonso NA, Gorman MA, Charlton WM, Scott BR, Kraus KM, Meredith SJ, Talwar S, Bergin PF, Jha AJ, McGee S, Nehete PV, Pryor TA, Spears I, Chen AT, Kelley B, Nez NR, Ertl WJ, Hull BR, Blumenthal S, Patterson JT, Flynn C, Ross RC, Agarwal A, Weiss DB, Hadeed MM, Yarboro SR, Daoud T, McVey ED, Whiting PS, Domes C, Goodspeed DC, Kuhn GR, Boyce R, Libos A, Mitchell PM, Moreno-Diaz AF, Ponce RB, Stinner DJ, Tatman LM, Velasco-Castro J, Trochez K, Satpathy J, Zuelzer DA, Potter BK. Intrawound Tobramycin Plus Vancomycin to Prevent Surgical Site Infection in Tibial Fractures: The TOBRA Randomized Clinical Trial. JAMA. 2026 May 12; 335(18):1586-1595.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|